Merit Medical Systems, Inc.
MMSI
Get informed when a big investor buys or sells
+ FollowCurrent Fair Value
149.1% upsideUndervalued by 149.1% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $3.76 Billion |
|---|---|
| Enterprise Value | $4.13 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $2.17 |
| Beta | 0.58 |
| Outstanding Shares | 59,510,000 |
Return
| Return on Equity | 8.57% |
|---|---|
| Return on Assets | 5.12% |
| Return on Invested Capital | 7.64% |
Valuation & Multiples
| P/E Ratio | 26.93 |
|---|---|
| PEG | 74.85 |
| Price to Sales | 2.43 |
| Price to Book Ratio | 2.25 |
| Enterprise Value to Revenue | 2.67 |
| Enterprise Value to EBIT | 21.59 |
| Enterprise Value to Net Income | 29 |
| Total Debt to Enterprise | 0.21 |
| Debt to Equity | 0.52 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Next Earnings Call
Institutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0006▼ 5.46% |
|---|---|
| Total Calls | 860,880▼ 7.95% |
| Total Puts | 500▼ 99.03% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 100.23%▼ 4.76% |
|---|---|
| Total Invested | $4.10B▼ 25.19% |
| Investors Holding | 401▲ 4.00% |
ESG Score
No data
About Merit Medical Systems, Inc.
CEO: Fred Lampropoulos Relevant Senate Committees
Controls taxation, trade, and entitlement spending; its decisions on corporate tax policy, tariffs, and Medicare reimbursement rates are crucial for MMSI's profitability and market access.
Allocates federal spending; its subcommittees determine funding for federal healthcare programs (e.g., VA, NIH) and government agencies, directly impacting purchasing power for medical instruments and research.
Regulates the FDA, which is the primary approval body for medical devices; its decisions on regulatory frameworks and labor laws directly impact MMSI's product development, approval process, and manufacturing costs.
Oversees antitrust laws and intellectual property; critical for MMSI's potential mergers/acquisitions and the protection of its patented medical device technologies.
Oversees the Department of Veterans Affairs; its funding and policy decisions directly impact government healthcare contractors and medical device manufacturers like MMSI, which supply the VA system.